Pub Date : 2023-01-24DOI: 10.1108/ijhg-12-2022-0108
Mohammad Azhar Ud Din, Muzffar Hussain Dar, S. Haseen
PurposeThe study aims to compare India's public health expenditure at the international and state levels. The paper also empirically examines the regional disparities in NRHM spending across the 21 selected states of India.Design/methodology/approachThe tools of absolute β-and σ-convergence are used in the analysis to test the regional convergence. The average annual growth rate across the states is the dependent variable for β-convergence, and time is the second dependent variable but is used for s-convergence. In contrast, the initial value of NRHM expenditure and the coefficient of variation of NRHM expenditure are used as independent variables, respectively. Descriptive statistics are also used for the study. The data are annual and cover the panel from 2007 to 2020.FindingsThe study attests to the hypothesis of β-and σ-convergence for the selected states in the period mentioned. The observed convergence in NRHM expenditure is due to the shift in the government's attention from the non-high focus high focus states to high states through the national rural health mission policy. The coefficient of variation across the states also shows a declining trend and provides the robustness of the σ-convergence.Originality/valueAs far as the literature is concerned, none of the existing studies examines the convergence of a public health expenditure scheme like the National Rural Health Mission across the Indian states by applying the techniques of β-and σ-convergence. The novelty of the study is using the newly updated dataset and validating the convergence hypotheses in the National Rural Health Mission expenditure case.
{"title":"Inter-state disparities in government health expenditure in India: a study of national rural health mission","authors":"Mohammad Azhar Ud Din, Muzffar Hussain Dar, S. Haseen","doi":"10.1108/ijhg-12-2022-0108","DOIUrl":"https://doi.org/10.1108/ijhg-12-2022-0108","url":null,"abstract":"PurposeThe study aims to compare India's public health expenditure at the international and state levels. The paper also empirically examines the regional disparities in NRHM spending across the 21 selected states of India.Design/methodology/approachThe tools of absolute β-and σ-convergence are used in the analysis to test the regional convergence. The average annual growth rate across the states is the dependent variable for β-convergence, and time is the second dependent variable but is used for s-convergence. In contrast, the initial value of NRHM expenditure and the coefficient of variation of NRHM expenditure are used as independent variables, respectively. Descriptive statistics are also used for the study. The data are annual and cover the panel from 2007 to 2020.FindingsThe study attests to the hypothesis of β-and σ-convergence for the selected states in the period mentioned. The observed convergence in NRHM expenditure is due to the shift in the government's attention from the non-high focus high focus states to high states through the national rural health mission policy. The coefficient of variation across the states also shows a declining trend and provides the robustness of the σ-convergence.Originality/valueAs far as the literature is concerned, none of the existing studies examines the convergence of a public health expenditure scheme like the National Rural Health Mission across the Indian states by applying the techniques of β-and σ-convergence. The novelty of the study is using the newly updated dataset and validating the convergence hypotheses in the National Rural Health Mission expenditure case.","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46059787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-29DOI: 10.1108/ijhg-07-2022-0068
S. Wiig, Cecilie Haraldseid-Driftland, Heidi Dombestein, Hilda Bø Lyng, E. Ree, Birte Fagerdal, Lene Schibevaag, Veslemøy Guise
PurposeResilience in healthcare is fundamental for what constitutes quality in healthcare. To understand healthcare resilience, resilience research needs a multilevel perspective, diverse research designs, and taking advantage of different data sources. However, approaching resilience researchers as a data source is a new approach within this field and needs careful consideration to ensure that research is trustworthy and ethically sound. The aim of this short “backstage” general review paper is to give a snapshot of how the Resilience in Healthcare (RiH) research program identified and dealt with potential methodological and ethical challenges in researching researcher colleagues.Design/methodology/approachThe authors first provide an overview of the main challenges and benefits from the literature on researching researcher colleagues. Second, the authors demonstrate how this literature was used to guide strategies and principles adopted in the RiH research process.FindingsThe paper describes established principles and a checklist for data collection and analysis to overcome potential dilemmas and challenges to ensure trustworthiness and transparency in the process.Originality/valueMining the knowledge and experience of resilience researchers is fundamental for taking the research field to the next step, and furthermore an approach that is relevant across different research fields. This paper provides guidance on how other research projects can approach researcher colleagues in similar ways to gain new insight, build theory and advance their research field based on insider competence.
{"title":"Backstage researching resilience researchers – dilemmas and principles for data collection in the resilience in healthcare research program","authors":"S. Wiig, Cecilie Haraldseid-Driftland, Heidi Dombestein, Hilda Bø Lyng, E. Ree, Birte Fagerdal, Lene Schibevaag, Veslemøy Guise","doi":"10.1108/ijhg-07-2022-0068","DOIUrl":"https://doi.org/10.1108/ijhg-07-2022-0068","url":null,"abstract":"PurposeResilience in healthcare is fundamental for what constitutes quality in healthcare. To understand healthcare resilience, resilience research needs a multilevel perspective, diverse research designs, and taking advantage of different data sources. However, approaching resilience researchers as a data source is a new approach within this field and needs careful consideration to ensure that research is trustworthy and ethically sound. The aim of this short “backstage” general review paper is to give a snapshot of how the Resilience in Healthcare (RiH) research program identified and dealt with potential methodological and ethical challenges in researching researcher colleagues.Design/methodology/approachThe authors first provide an overview of the main challenges and benefits from the literature on researching researcher colleagues. Second, the authors demonstrate how this literature was used to guide strategies and principles adopted in the RiH research process.FindingsThe paper describes established principles and a checklist for data collection and analysis to overcome potential dilemmas and challenges to ensure trustworthiness and transparency in the process.Originality/valueMining the knowledge and experience of resilience researchers is fundamental for taking the research field to the next step, and furthermore an approach that is relevant across different research fields. This paper provides guidance on how other research projects can approach researcher colleagues in similar ways to gain new insight, build theory and advance their research field based on insider competence.","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45705827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-12-27DOI: 10.1108/ijhg-04-2022-0043
Yassmine Mourajid, Asmaa Ghafili, M. Chahboune, A. Hilali, Chaima Fihri Fassi
PurposeThe purpose of this paper is to analyse the framework of hospital governance in order to understanding the persistence of dysfunctions that have caused the deterioration of the image and quality of Moroccan public hospital services.Design/methodology/approachThe analysis of the hospital governance model has used a conceptual framework examining four dimensions: institutional, financial, accountability and decision-making dimensions. This framework operationalization was highlighted through a documentary review of the main regulatory and legal texts as well as multiple case studies, using semi-structured interviews with the key stakeholders, considering their expertise and implication in the governance process.FindingsThe study was able to highlight that the governance structure of Moroccan public hospitals has been subject to numerous legislative provisions and modern management instruments. However, the limited autonomy, the resources shortage, dilapidated equipment, the chronic budget deficit, staff demotivation, the lack of accountability mechanisms have led to the deterioration of the quality of care and, hence, to patient's dissatisfaction.Practical implicationsThe analysis formed the basis for a series of recommendations. These were mainly aimed at rethinking the current governance model by setting up an institutional policy to improve the current governance structures and monitoring mechanisms of hospitals, as well as revising the instruments for planning and evaluating the provision of care and services according to the real needs of the population, taking into account the financial limits.Social implicationsThe hospital governance framework is proving to be a powerful tool for identifying the problems contributing to sub-optimal hospital performance, and calls for policy interventions to improve the organisation organization and delivery of hospital services with greater patient involvement.Originality/valueThis study was the first to analyse the Moroccan hospital governance model, using a comprehensive and structured evaluation methodology designed for public hospitals and supported by extensive data collection which made it possible to offer a broad and in-depth view of the actual functioning of these institutions.
{"title":"Governance in Moroccan public hospitals: critical analysis and perspectives for action","authors":"Yassmine Mourajid, Asmaa Ghafili, M. Chahboune, A. Hilali, Chaima Fihri Fassi","doi":"10.1108/ijhg-04-2022-0043","DOIUrl":"https://doi.org/10.1108/ijhg-04-2022-0043","url":null,"abstract":"PurposeThe purpose of this paper is to analyse the framework of hospital governance in order to understanding the persistence of dysfunctions that have caused the deterioration of the image and quality of Moroccan public hospital services.Design/methodology/approachThe analysis of the hospital governance model has used a conceptual framework examining four dimensions: institutional, financial, accountability and decision-making dimensions. This framework operationalization was highlighted through a documentary review of the main regulatory and legal texts as well as multiple case studies, using semi-structured interviews with the key stakeholders, considering their expertise and implication in the governance process.FindingsThe study was able to highlight that the governance structure of Moroccan public hospitals has been subject to numerous legislative provisions and modern management instruments. However, the limited autonomy, the resources shortage, dilapidated equipment, the chronic budget deficit, staff demotivation, the lack of accountability mechanisms have led to the deterioration of the quality of care and, hence, to patient's dissatisfaction.Practical implicationsThe analysis formed the basis for a series of recommendations. These were mainly aimed at rethinking the current governance model by setting up an institutional policy to improve the current governance structures and monitoring mechanisms of hospitals, as well as revising the instruments for planning and evaluating the provision of care and services according to the real needs of the population, taking into account the financial limits.Social implicationsThe hospital governance framework is proving to be a powerful tool for identifying the problems contributing to sub-optimal hospital performance, and calls for policy interventions to improve the organisation organization and delivery of hospital services with greater patient involvement.Originality/valueThis study was the first to analyse the Moroccan hospital governance model, using a comprehensive and structured evaluation methodology designed for public hospitals and supported by extensive data collection which made it possible to offer a broad and in-depth view of the actual functioning of these institutions.","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41498098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
PurposeThe unresolved crisis scenario and a prolonged COVID-19 pandemic increased social inequalities, mainly affecting the most vulnerable groups to access health services. The data in Pakistan show that health coverage benefits less than half of the population and a weak health system forces households to finance their health with out-of-pocket expenses. Therefore, it is a pending task to guarantee universal health coverage and design sustainable and inclusive policies to finance and provide health services. This study aims to offer a unique solution for health financing to Pakistan.Design/methodology/approachThis study uses the VECM model by employing the data from Pakistan to indicate sustainable policies for health financing.FindingsThe results of this research show that direct taxes have a positive impact on public health expenditure; on the contrary, indirect taxes have a negative impact; it also confirms the importance of considering the direct tax based on high-income quintiles to guarantee equality and Access to health for all that contributes to human development.Practical implicationsThis article leads to the design of a new health system that will be useful for improving the health of Pakistan by presenting a solution to enhance health financing. Meanwhile, Pakistan will experience better conditions in the face of health crises.Social implicationsImproving health financing through the equality approach can provide public access to the health system and strengthen the positive effects of the health system on socio-economic relations.Originality/valueThis paper provides a unique solution for the ministry of health of Pakistan, International organisations and national authorities to reach a high level of health coverage without any cost to the financial system and increase the cost of living of the Pakistani people.HighlightsIncrease efficient health financing by integrating health coverage programmes.Implementing direct taxes based on income quintiles improves health equality.Indirect tax policies will not positively contribute to health financing.Improving health financing efficiency decreases health inequality.
{"title":"Inclusive policies for health financing towards universal health coverage in Pakistan: direct or indirect taxes","authors":"Amirreza Kazemikhasragh, Marianna Vanessa Buoni Pineda","doi":"10.1108/ijhg-06-2022-0054","DOIUrl":"https://doi.org/10.1108/ijhg-06-2022-0054","url":null,"abstract":"PurposeThe unresolved crisis scenario and a prolonged COVID-19 pandemic increased social inequalities, mainly affecting the most vulnerable groups to access health services. The data in Pakistan show that health coverage benefits less than half of the population and a weak health system forces households to finance their health with out-of-pocket expenses. Therefore, it is a pending task to guarantee universal health coverage and design sustainable and inclusive policies to finance and provide health services. This study aims to offer a unique solution for health financing to Pakistan.Design/methodology/approachThis study uses the VECM model by employing the data from Pakistan to indicate sustainable policies for health financing.FindingsThe results of this research show that direct taxes have a positive impact on public health expenditure; on the contrary, indirect taxes have a negative impact; it also confirms the importance of considering the direct tax based on high-income quintiles to guarantee equality and Access to health for all that contributes to human development.Practical implicationsThis article leads to the design of a new health system that will be useful for improving the health of Pakistan by presenting a solution to enhance health financing. Meanwhile, Pakistan will experience better conditions in the face of health crises.Social implicationsImproving health financing through the equality approach can provide public access to the health system and strengthen the positive effects of the health system on socio-economic relations.Originality/valueThis paper provides a unique solution for the ministry of health of Pakistan, International organisations and national authorities to reach a high level of health coverage without any cost to the financial system and increase the cost of living of the Pakistani people.HighlightsIncrease efficient health financing by integrating health coverage programmes.Implementing direct taxes based on income quintiles improves health equality.Indirect tax policies will not positively contribute to health financing.Improving health financing efficiency decreases health inequality.","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48635132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-22DOI: 10.1108/ijhg-12-2021-0123
Lu Liu
PurposeThis research studies the effect of deregulation of price cap in pharmaceutical market. Price regulation (either through price cap or reference price) is common practice in the pharmaceutical market but recently there are increasing voices calling for deregulation claiming that deregulation could help in lowering drug price and increase revenue of pharmaceutical firms. Upon those callings, Chinese government removed the price cap regulation in June 2015. The author uses this natural policy experiment to study this effect.Design/methodology/approachIn this study, the author applied the interrupted time series analysis (ITSA) on the revenue data of nine categories of both generic and branded drugs in China from March 2011 to August 2016 (the time frame includes both before and after of the initialization of the deregulation) and analyzed the effect of deregulation.FindingsThe results showed that, whether the revenue of drugs will increase or decrease after the deregulation of price cap depends on the level of competition and the change of patterns of the branded and generic drugs are different. When HHI (Herfindahl–Hirschman index) is sufficiently low (competition is high), revenue does not change as a result of deregulation, when HHI is moderately low (moderate competition), revenue from generic drugs will decrease significantly and revenue from branded drugs will increase significantly, and when HHI is high (low competition), revenue from generic drugs will increase significantly and revenue from branded drugs will decrease significantly.Originality/valueThis is a unique study with a unique data set. Most previous studies focus on regulation of drug price and analyze how this may affect drug revenue; however, this is a natural policy experiment of de-regulation. Moreover, previously most studies focus on reference pricing regulation and this is price-cap, a different mechanism that is rarely studied. The originality/value is high of this article.
{"title":"Deregulation on branded and generic drugs price and its effect: a study of Chinese pharmaceutical market","authors":"Lu Liu","doi":"10.1108/ijhg-12-2021-0123","DOIUrl":"https://doi.org/10.1108/ijhg-12-2021-0123","url":null,"abstract":"PurposeThis research studies the effect of deregulation of price cap in pharmaceutical market. Price regulation (either through price cap or reference price) is common practice in the pharmaceutical market but recently there are increasing voices calling for deregulation claiming that deregulation could help in lowering drug price and increase revenue of pharmaceutical firms. Upon those callings, Chinese government removed the price cap regulation in June 2015. The author uses this natural policy experiment to study this effect.Design/methodology/approachIn this study, the author applied the interrupted time series analysis (ITSA) on the revenue data of nine categories of both generic and branded drugs in China from March 2011 to August 2016 (the time frame includes both before and after of the initialization of the deregulation) and analyzed the effect of deregulation.FindingsThe results showed that, whether the revenue of drugs will increase or decrease after the deregulation of price cap depends on the level of competition and the change of patterns of the branded and generic drugs are different. When HHI (Herfindahl–Hirschman index) is sufficiently low (competition is high), revenue does not change as a result of deregulation, when HHI is moderately low (moderate competition), revenue from generic drugs will decrease significantly and revenue from branded drugs will increase significantly, and when HHI is high (low competition), revenue from generic drugs will increase significantly and revenue from branded drugs will decrease significantly.Originality/valueThis is a unique study with a unique data set. Most previous studies focus on regulation of drug price and analyze how this may affect drug revenue; however, this is a natural policy experiment of de-regulation. Moreover, previously most studies focus on reference pricing regulation and this is price-cap, a different mechanism that is rarely studied. The originality/value is high of this article.","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44673845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.1108/ijhg-12-2022-150
F. M. MacVane Phipps
{"title":"IJHG 27.4 Review","authors":"F. M. MacVane Phipps","doi":"10.1108/ijhg-12-2022-150","DOIUrl":"https://doi.org/10.1108/ijhg-12-2022-150","url":null,"abstract":"","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46494730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-09-12DOI: 10.1108/ijhg-07-2022-0072
Margarita Peonides, V. Knoll, Nina Gerstner, Raffael Heiss, Markus Frischhut, N. Gokani
PurposeThis review explores the phenomenon of front-of-pack nutrition labels (FoPNLs) in the European Union (EU). FoPNLs highlight the nutritional quality of food and non-alcoholic beverages and help consumers to make healthier choices. The review explores different types of FoPNLs and evaluates their effectiveness.Design/methodology/approachA policy analysis was conducted, relying on extant academic literature, grey literature and policy documents. The use of current FoPNLs is interpreted in light of national and economic interests.FindingsOur review identifies and describes seven government endorsed FoPNLs that are currently used in the EU. Five are positive endorsement labels (Croatia, Czech Republic, Denmark, Lithuania, Slovenia and Sweden), which only provide a positive indication on more healthy products. The Keyhole is used in three EU countries (Denmark, Lithuania and Sweden), while the others are used in one country each. The Nutri-Score represents a summary label, which provides an overall grade of how healthy a product is. It is used in six countries (Belgium, France, Germany, Netherlands, Spain and Luxembourg). Finally, the Nutrinform battery is a nutrient-specific non-interpretive scheme, indicating the content of nutrients in a portion of a food product. All identified labels are only used on a voluntary basis, encouraging selective use.Originality/valueThis review contributes to a significant discussion about food labeling in the EU. It summarizes existing approaches and evaluates them in terms of their effectiveness. The current schemes in use reflect regional clustering. The most common scheme is the Nutri-Score. This is predominantly found in western EU states. Another major label is the Keyhole, with summary endorsement schemes being prevalent in northern EU states. The least common is Nutrinform, which has some support in southern EU states. The Nutri-score is most effective although economic interests are pushing for the Nutrinform battery in a small number of states. Finally, the review suggests that all existing FoPNLs are voluntary, these labels fail to provide consumers with adequate information about nutrition quality of food products. The EU needs to mobilize support to agree on a single one.
{"title":"Food labeling in the European Union: a review of existing approaches","authors":"Margarita Peonides, V. Knoll, Nina Gerstner, Raffael Heiss, Markus Frischhut, N. Gokani","doi":"10.1108/ijhg-07-2022-0072","DOIUrl":"https://doi.org/10.1108/ijhg-07-2022-0072","url":null,"abstract":"PurposeThis review explores the phenomenon of front-of-pack nutrition labels (FoPNLs) in the European Union (EU). FoPNLs highlight the nutritional quality of food and non-alcoholic beverages and help consumers to make healthier choices. The review explores different types of FoPNLs and evaluates their effectiveness.Design/methodology/approachA policy analysis was conducted, relying on extant academic literature, grey literature and policy documents. The use of current FoPNLs is interpreted in light of national and economic interests.FindingsOur review identifies and describes seven government endorsed FoPNLs that are currently used in the EU. Five are positive endorsement labels (Croatia, Czech Republic, Denmark, Lithuania, Slovenia and Sweden), which only provide a positive indication on more healthy products. The Keyhole is used in three EU countries (Denmark, Lithuania and Sweden), while the others are used in one country each. The Nutri-Score represents a summary label, which provides an overall grade of how healthy a product is. It is used in six countries (Belgium, France, Germany, Netherlands, Spain and Luxembourg). Finally, the Nutrinform battery is a nutrient-specific non-interpretive scheme, indicating the content of nutrients in a portion of a food product. All identified labels are only used on a voluntary basis, encouraging selective use.Originality/valueThis review contributes to a significant discussion about food labeling in the EU. It summarizes existing approaches and evaluates them in terms of their effectiveness. The current schemes in use reflect regional clustering. The most common scheme is the Nutri-Score. This is predominantly found in western EU states. Another major label is the Keyhole, with summary endorsement schemes being prevalent in northern EU states. The least common is Nutrinform, which has some support in southern EU states. The Nutri-score is most effective although economic interests are pushing for the Nutrinform battery in a small number of states. Finally, the review suggests that all existing FoPNLs are voluntary, these labels fail to provide consumers with adequate information about nutrition quality of food products. The EU needs to mobilize support to agree on a single one.","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45133218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-26DOI: 10.1108/ijhg-06-2022-0053
A. Shodunke, S. Oladipupo, O. Tayo-Ladega, Adebusayo Joel Alowolodu, Yusuf Olalekan Adebayo
PurposeGiven the efficacy of a robust public healthcare system in handling public health emergencies, the rapid rate of COVID-19 pandemic infection in early-hit (advanced) countries with competent healthcare system is intriguing. The popular public health argument supports the strengthening of the healthcare system as a significant response strategy to minimize infection. Hence, this paper examines the catalysts that exacerbated the pandemic’s rapid spread in these countries despite the sound state of their healthcare system. Also, it assesses the condition of Nigerian public healthcare system in the lights of the novel COVID-19 pandemic and suggests the need for improvement and effective functioning.Design/methodology/approachThis paper uses a documentary approach to establish the authors’ opinion on the subject matter under investigation.FindingsFactors such as climate, temperature, and humidity levels played a key role in infection in the winter of 2020. These factors facilitated for the pandemic’s rapid spread in advanced countries. In peripheral countries like Nigeria, the public healthcare system is burdened by a lack of funding, an insufficiency in welfare and training for healthcare staff and facilities and other operational challenges. Hence, the effective management of COVID-19 outbreak in Nigeria relative to advanced countries was hindered by the inadequacies mentioned above.Originality/valueThis paper provides an understanding on the condition of public healthcare system in peripheral nations in relation to the healthcare system advisories from the World Health Organization (WHO) in the context of handling the pandemic outbreak. Also, it explains the catalysts that heightened the pandemic’s rapid spread in advanced countries despite the higher capacity of their healthcare system to manage health emergencies.
{"title":"COVID-19 pandemic, global advisories and the imperatives of strengthening the public healthcare system: Nigeria in context","authors":"A. Shodunke, S. Oladipupo, O. Tayo-Ladega, Adebusayo Joel Alowolodu, Yusuf Olalekan Adebayo","doi":"10.1108/ijhg-06-2022-0053","DOIUrl":"https://doi.org/10.1108/ijhg-06-2022-0053","url":null,"abstract":"PurposeGiven the efficacy of a robust public healthcare system in handling public health emergencies, the rapid rate of COVID-19 pandemic infection in early-hit (advanced) countries with competent healthcare system is intriguing. The popular public health argument supports the strengthening of the healthcare system as a significant response strategy to minimize infection. Hence, this paper examines the catalysts that exacerbated the pandemic’s rapid spread in these countries despite the sound state of their healthcare system. Also, it assesses the condition of Nigerian public healthcare system in the lights of the novel COVID-19 pandemic and suggests the need for improvement and effective functioning.Design/methodology/approachThis paper uses a documentary approach to establish the authors’ opinion on the subject matter under investigation.FindingsFactors such as climate, temperature, and humidity levels played a key role in infection in the winter of 2020. These factors facilitated for the pandemic’s rapid spread in advanced countries. In peripheral countries like Nigeria, the public healthcare system is burdened by a lack of funding, an insufficiency in welfare and training for healthcare staff and facilities and other operational challenges. Hence, the effective management of COVID-19 outbreak in Nigeria relative to advanced countries was hindered by the inadequacies mentioned above.Originality/valueThis paper provides an understanding on the condition of public healthcare system in peripheral nations in relation to the healthcare system advisories from the World Health Organization (WHO) in the context of handling the pandemic outbreak. Also, it explains the catalysts that heightened the pandemic’s rapid spread in advanced countries despite the higher capacity of their healthcare system to manage health emergencies.","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43035360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-24DOI: 10.1108/ijhg-02-2022-0017
Widad Bousfot, S. Saadi, M. Djebabra
PurposeThe objective of this article is to carry out an exploratory study on the emergence of health and safety committees (HSC) in Algerian companies.Design/methodology/approachThe methodology chosen, governed by the systemic approach, is centered on the exploration of HSC emergence factors in companies.FindingsThe suggested method consists in defining hypotheses found in the literature on the emergence of HSC in order to affirm or refute them in the case of Algerian companies.Research limitations/implicationsDespite the fact that a good number of Algerian industrial companies were solicited; the number of respondents was limited. This limitation confirms the difficulty commonly encountered in exploratory studies by questionnaire.Practical implicationsThe results of this exploratory study serve as a basis for the elaboration of a national action plan dedicated to HSC emergence in Algerian companies.Originality/valueThis is the first study conducted in Algerian companies on HSC emergence. The identification of emergence problems allows drawing up an effective action plan to solve them.
{"title":"Emergence of joint health and safety committees in Algerian companies: an exploratory study","authors":"Widad Bousfot, S. Saadi, M. Djebabra","doi":"10.1108/ijhg-02-2022-0017","DOIUrl":"https://doi.org/10.1108/ijhg-02-2022-0017","url":null,"abstract":"PurposeThe objective of this article is to carry out an exploratory study on the emergence of health and safety committees (HSC) in Algerian companies.Design/methodology/approachThe methodology chosen, governed by the systemic approach, is centered on the exploration of HSC emergence factors in companies.FindingsThe suggested method consists in defining hypotheses found in the literature on the emergence of HSC in order to affirm or refute them in the case of Algerian companies.Research limitations/implicationsDespite the fact that a good number of Algerian industrial companies were solicited; the number of respondents was limited. This limitation confirms the difficulty commonly encountered in exploratory studies by questionnaire.Practical implicationsThe results of this exploratory study serve as a basis for the elaboration of a national action plan dedicated to HSC emergence in Algerian companies.Originality/valueThis is the first study conducted in Algerian companies on HSC emergence. The identification of emergence problems allows drawing up an effective action plan to solve them.","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47581778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-08-12DOI: 10.1108/ijhg-09-2022-148
F. M. MacVane Phipps
{"title":"IJHG 27.3 Review","authors":"F. M. MacVane Phipps","doi":"10.1108/ijhg-09-2022-148","DOIUrl":"https://doi.org/10.1108/ijhg-09-2022-148","url":null,"abstract":"","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2022-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48103186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：